Bicycle Therapeutics plc (BCYC) Financials

BCYC Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 652.4 million 98.1 million
Dec. 31, 2025 717.6 million 107.6 million
Sept. 30, 2025 764.0 million 145.5 million
June 30, 2025 832.2 million 163.3 million

BCYC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -66.6 million 6.9 million
Dec. 31, 2025 -17.2 million -27.8 million
Sept. 30, 2025 -71.8 million 8.8 million
June 30, 2025 -73.3 million 9.4 million

BCYC Net Income

No data available :(

BCYC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 559.5 million - 13.9 million
Dec. 31, 2025 628.1 million - 14.8 million
Sept. 30, 2025 648.3 million - 5.7 million
June 30, 2025 721.5 million - 2.6 million

BCYC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 69.7 million
Dec. 31, 2025 69.4 million
Sept. 30, 2025 69.3 million
June 30, 2025 69.3 million

BCYC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 713000 48.9 million 17.6 million -
Dec. 31, 2025 1.8 million 51.8 million 20.8 million 199000
Sept. 30, 2025 674000 58.4 million 19.0 million -
June 30, 2025 498000 71.0 million 19.2 million -

BCYC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 887000 -
Dec. 31, 2025 48.0 million 35.1 million
Sept. 30, 2025 11.7 million -
June 30, 2025 2.9 million 71.0 million

BCYC Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BCYC

Price: $4.05

52 week price:
4.03
9.36

Earnings Per Share: -3.24 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United Kingdom

Volume: 365200

Market Capitalization: 291.5 million

Links: